YHOO 51.68 Yahoo! Inc $YHOO Hit a 52 week high of 52.00

New Post Public Reply Private Reply Replies (0) Message Board

Nov 17, 2014 at 12:36 PM

YHOO 51.68 Yahoo! Inc $YHOO Hit a 52 week high of 52.00 Closing the day 09:45 at 51.68 -0.07 -0.14% With a day low of 51.61 and a total volume of 2,153,853.

YHOO Recent Posts: http://investorshangout.com/Yahoo-Inc-YHOO-55946/

YHOO Yahoo! Inc Recent Headline News

Will Yahoo! (YHOO) Stock Rise Today on Positive Analyst Note?
at The Street - 1 hr 16 mins ago
Yahoo! (YHOO) received a positive note by analysts at Citigroup this morning, that said investors wanting Alibaba (BABA) should consider Yahoo!
YHOO: 51.28 (-0.47), BABA: 113.80 (-1.30)

Insider Trading Alerts for Tesla, Globalstar, Boston Scientific, Apple, Yahoo, and Twitter
PR Newswire - Mon Nov 17, 7:45AM CST
Pennystocksinsiders.com (PSI) released FREE insider trading reports for US market investors to track the following active stocks and penny stocks: Tesla (NASDAQ:TSLA), Globalstar (NYSEMKT:GSAT), Boston Scientific (NYSE:BSX), Apple (NASDAQ:AAPL), Yahoo! (NASDAQ:YHOO), and Plug Power (NASDAQ

LUG).
BSX: 13.38 (+0.02), YHOO: 51.28 (-0.47), TSLA: 253.19 (-5.49), PLUG: 3.75 (+0.03), TWTR: 40.66 (-1.19), AAPL: 113.95 (-0.23), GSAT: 2.90 (-0.07)

Wall Street Breakfast: Nikkei Dives As Japan Slips Into Recession
Wall Street Breakfast - Seeking Alpha - Mon Nov 17, 5:30AM CST
Outstanding Performance Article Rewards We're excited to announce our latest two Outstanding Performance award winners. Each author receives $2,500. Read more about our Outstanding Performance award winners here . Winner #1: Top long idea...
VRX: 134.32 (+0.11), ACT: 248.09 (+4.32), F: 15.36 (+0.22), FB: 74.17 (-0.71), PFE: 30.14 (-0.20), AGN: 209.82 (+11.17), YHOO: 51.28 (-0.47), PBR: 9.53 (-0.42), DFS: 65.06 (+0.08), DTSI: 32.75 (-0.28), SPY: 204.06 (-0.18), LNKD: 221.51 (-12.38), QQQ: 102.74 (-0.48), AME: 51.14 (-0.56), MRK: 59.55 (+0.48), AOL: 46.57 (+0.53), AZN: 72.18 (-0.67), GM: 32.21 (+0.42), CVEO: 10.61 (-0.03), DD: 70.38 (-0.42)

Activist Starboard buys stake in AOL
Seeking Alpha - at Seeking Alpha - Mon Nov 17, 2:38AM CST

YHOO: 51.28 (-0.47), AOL: 46.57 (+0.53)

Can Facebook's Privacy Basics Tool Boost User Growth? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Nov 14, 4:00PM CST
Facebook Inc. (FB) recently launched a new privacy tool called Privacy Basics.
YHOO: 51.28 (-0.47), FB: 74.17 (-0.71), GOOGL: 547.05 (-8.14), TWTR: 40.66 (-1.19)

After Yesterday's Rally of 2.48% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Fri Nov 14, 3:39PM CST
Yahoo! (NASDAQ:YHOO) traded in a range yesterday that spanned from a low of $50.47 to a high of $51.95. Yesterday, the shares gained 2.5%, which took the trading range above the 3-day high of $51.17 on volume of 28.7 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
YHOO: 51.28 (-0.47)

Yahoo! Rises 2.48% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Fri Nov 14, 3:39PM CST
Yahoo! (NASDAQ:YHOO) traded in a range yesterday that spanned from a low of $50.47 to a high of $51.95. Yesterday, the shares gained 2.5%, which took the trading range above the 3-day high of $51.17 on volume of 28.7 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
YHOO: 51.28 (-0.47)

ModernGraham Quarterly Valuation Of Yahoo
Benjamin Clark - at Seeking Alpha - Fri Nov 14, 3:36PM CST

YHOO: 51.28 (-0.47), BABA: 113.80 (-1.30)

Yahoo tops $51 as targets reach $61
Seeking Alpha - at Seeking Alpha - Fri Nov 14, 2:12PM CST

YHOO: 51.28 (-0.47)

Why S&P's Junk Rating on Twitter Bonds Is Good News -- for the Stock
at The Street - Fri Nov 14, 12:32PM CST
Standard & Poor's didn't get it wrong. It just pointed out that Twitter bonds pose a fair amount of risk for little reward. Here's how to do better.
YHOO: 51.28 (-0.47), AMZN: 319.28 (-8.54), SCTY: 53.50 (+0.48), FB: 74.17 (-0.71), TWTR: 40.66 (-1.19), BABA: 113.84 (-1.26)

One Reason Yahoo (YHOO) Stock Is Rising Today
at The Street - Fri Nov 14, 8:40AM CST
Shares of Yahoo (YHOO) are up in early morning trading on Friday after the company's price target was raised at Oppenheimer.
YHOO: 51.28 (-0.47)

Today's Market: Earnings And Restructuring Plans Driving These Stocks
Matthew Smith - at Seeking Alpha - Fri Nov 14, 8:15AM CST

YHOO: 51.28 (-0.47), CYBR: 45.26 (+0.89), FB: 74.17 (-0.71), FUEL: 18.14 (-0.51), TWTR: 40.66 (-1.19), CZR: 15.71 (-0.79)

Market Maker Surveillance Report. DNDN, YHOO, CRDC, FNMAS, SLTD, BABA, Highest Net Sell Volume and Negative Price Friction For Thursday, November 13th 2014
M2 - Fri Nov 14, 3:02AM CST
BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Thursday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Thursday there were 4759 companies with "abnormal" market making, 1814 companies with positive Friction Factors and 3114 companies with negative Friction Factors. Here is a list of the top companies with the highest net sell volume on Thursday and lowest negative price Friction (bearish). This means that there was more selling than buying in the stocks and their stock prices dropped faster with less Friction. Dendreon Corp (NASDAQ

NDN), Yahoo! Inc (NASDAQ:YHOO), Cardica Inc (NASDAQ:CRDC), Federal National Mortgage Association Fannie Mae (OTC:FNMAS), Solar3D Inc (OTC:SLTD), (NYSE:BABA). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .
YHOO: 51.28 (-0.47), DNDN: 0.16 (+0.05), CRDC: 0.85 (-0.01), BABA: 113.84 (-1.26)

Market Advance Spawns Many Winning Stocks
at Investor's Business Daily - Thu Nov 13, 5:58PM CST
A sharp advance in the stock market has resulted in many top-rated stocks making dramatic gains. Quite a few stocks have surged 15%, 20% or more from breakouts since the Oct. 21 market follow-through, which is a testimony about the rally's strength....
YHOO: 51.28 (-0.47), KNX: 30.67 (-0.15), DPZ: 91.72 (+0.26), QLYS: 35.75 (-0.88), ALK: 55.04 (-0.30), PAYC: 24.50 (+0.81), BABA: 113.84 (-1.26)

Yahoo's Acquisition Of BrightRoll Highly Accretive Over The Next 5 Years
Alex Cho - at Seeking Alpha - Thu Nov 13, 5:28PM CST

YHOO: 51.28 (-0.47)

Google's DoubleClick Goes Down, Online Ads Suffer Globally - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Nov 13, 1:30PM CST
Google Inc.'s (GOOGL) online advertisement service for publishers, DoubleClick, suffered an outage for nearly two hours due to a software glitch.
YHOO: 51.28 (-0.47), FB: 74.17 (-0.71), AKAM: 62.35 (-0.57), GOOGL: 547.05 (-8.14)

11 Earnings Reports Worth Paying Attention To
Brian Nelson - at Seeking Alpha - Thu Nov 13, 1:03PM CST

KO: 42.89 (+0.16), YHOO: 51.28 (-0.47), T: 35.83 (-0.07), ABT: 43.83 (+0.02), NSC: 115.89 (-0.14), UTX: 107.45 (unch), BRCM: 42.08 (-0.03), DDD: 34.96 (+0.89), KMB: 113.88 (+1.23), BA: 128.54 (-0.32), CLB: 136.93 (-1.97)

Twitter Up on Upgraded Long Term Outlook at Analyst Day - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Nov 13, 12:10PM CST
Micro-blogging site, Twitter Inc. (TWTR) held its first analyst day on Nov 12, 2014, following which shares of the company were up 7.45% ($2.95) and closed at $42.54.
YHOO: 51.28 (-0.47), FB: 74.17 (-0.71), GOOGL: 547.05 (-8.14), TWTR: 40.66 (-1.19)

20.4% Return Seen to Date on SmarTrend Yahoo! Call (YHOO)
Comtex SmarTrend(R) - Thu Nov 13, 10:22AM CST
SmarTrend identified an Uptrend for Yahoo! (NASDAQ:YHOO) on October 22nd, 2014 at $42.33. In approximately 3 weeks, Yahoo! has returned 20.43% as of today's recent price of $50.97.
YHOO: 51.28 (-0.47)

Cramer's Mad Money - The Container Store Looks Forward To The Holidays (11/12/14)
SA Editor Miriam Metzinger - Seeking Alpha - Thu Nov 13, 7:12AM CST
Stocks discussed on the in-depth session of Jim Cramer's Mad Money TV Program, Wednesday November 12. CEO Interview: Kip Tindell, The Container Store (NYSE: TCS ) The Container Store ( TCS ) doubled after its IPO last year, but has fallen...
YHOO: 51.28 (-0.47), SAVE: 75.98 (-0.17), PNRA: 169.80 (+0.04), FB: 74.17 (-0.71), CMG: 660.68 (-9.12), AAL: 44.15 (+0.14), TCS: 22.50 (-0.91), DOW: 50.86 (-0.51), AAPL: 113.95 (-0.23), BABA: 113.82 (-1.28)

Altaba Inc. (AABA) Stock Research Links

AABA Board Company Profile Buy Rating Time & Sales News Filings Financials

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

What to Expect: Your First Therapy Session Insights

Starting With the Unknown: The Therapy Journey Begins Rolling into that first therapy session can feel like walking into a mystery with no clues. You're not alone if it stirs up some nerves—most folks feel the same, especially when it's your first rodeo in mental health support. That's where Cody Luke and David Spencer of Luke and Spencer Behavioral Health, based out in...

ASTS Faces Crucial Deadline Amidst Legal Turmoil

Ah, the ticking clock in the world of stock investments, where a nifty little thing called a class action lawsuit can flip your investment on its head. Right now, AST SpaceMobile (NASDAQ: ASTS) investors are staring down the barrel of one such lawsuit. With the November 13, 2026, deadline looming, it's time to sort the facts from the muck. Pins and Needles for ASTS...

Quest Diagnostics Faces Class Action After Data Breach

Data Breach Rocks Quest Diagnostics October 2026 caught Quest Diagnostics in a bind they wish they could escape—a classic tech breach with personal info hanging out to dry. When a cyber ghost slipped into Quest's Quanum Lab Services Manager, it wasn't to deliver flowers. Nope, this unauthorized access was no friendly visit, forcing Quest to scream foul and play serious...

Millrose Faces Securities Fraud Suit Amidst Decline

Dark Clouds Over Millrose Properties Holy smokes, folks, if Millrose Properties thought it could skirt under the radar, they were dead wrong. The curtain's been peeled back, and what do we see? A mess of securities fraud allegations and financial hiccups that’s driving its shareholders mad. October wasn’t too friendly—Hunterbrook Media dropped a bombshell revealing...

John Wong's Decade as Estate Planning Specialist

One man's legacy isn’t built overnight, especially not in estate planning. And John L. Wong's decade of being a certified specialist by the State Bar of California tells a story of perseverance and grit. Now, at the helm of Modern Wealth Law in Irvine, California, Wong is a name that echoes through the halls of estate planning law with authority and respect. Creating...

DIRECTV Bags New NHL Deals: Stakes for Sports Fans

NHL Fans, Strap in: DIRECTV Expands Its Lineup In a world where keeping up with your favorite team gets tougher each day, DIRECTV just lobbed a puck right into the net with their latest play. They've snagged a multi-year deal with the NHL for the Carolina Hurricanes, Columbus Blue Jackets, Minnesota Wild, and St. Louis Blues networks. It's a game changer, folks. If you...

SLM Faces Legal Scrutiny as Losses Mount Amid Pause

SLM's Latest Troubles: Legal and Financial Impact Ah, student loans—not just a headache for borrowers but now for lenders too. SLM Corporation, that name we know all too well in the student debt circus, has hit a snag. They've paused most of their third-party recovery activities. Let's dig in: net charge-offs for SLM in the third quarter shot up to a hefty $90.4...

Amgen's IMDELLTRA® Shows Promise in SCLC Battle

Breakthrough Results in SCLC Treatment For years, small cell lung cancer (SCLC) has been the unruly beast in the oncology world, defying treatment advances and keeping survival rates stubbornly low. This nasty foe might just have met its match, folks. Amgen (NASDAQ:AMGN) announced results from their Phase 3 DeLLphi-305 trial that show their drug IMDELLTRA®, when teamed...

Lilly's Sofe-M Shakes Up Ovarian Cancer Treatment

Ovarian Cancer Treatment Sees a New Challenger Alright, folks, Eli Lilly (NYSE:LLY) is stepping up with their latest findings in ovarian cancer treatment, and it's got plenty of people in a buzz. They've dropped new data for their investigational drug, Sofetabart mipitecan, or 'Sofe-M' for short, which targets this unrelenting disease with a punch that’s hard to ignore....

Tony Perkins' Church Tour amid Controversial Vote

Lining the pews in Missouri and Kansas, folks are about to get a powerful dose of Tony Perkins this weekend. The Family Research Council President is driving straight into the heart of both spiritual and political fervor at a couple of church stops on Sunday, October 25—right on the doorstep of a crucial vote in Missouri. Taking the Stage in a Time of Tension Now,...